Effect of Anti-diabetic Drugs on Bone Metabolism and Glycemic Variability.A Comparison Between Vildagliptin and Gliclazide MR
Phase of Trial: Phase IV
Latest Information Update: 01 May 2018
Price : $35 *
At a glance
- Drugs Gliclazide (Primary) ; Vildagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms BONEGLYC
- 31 Aug 2018 Biomarkers information updated
- 09 Feb 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Jul 2013 Planned end date changed from 1 Apr 2014 to 1 Apr 2015 as reported by ClinicalTrials.gov record.